Entasis Therapeutics Holdings Inc
(ETTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,547 | 32,307 | 44,124 | 56,406 | 44,937 |
| Receivables | 1,146 | 1,258 | 2,967 | 2,657 | 2,559 |
| Other current assets | 697 | 496 | 512 | 888 | 1,338 |
| TOTAL | $39,880 | $39,815 | $49,746 | $62,422 | $51,545 |
| Non-Current Assets | |||||
| PPE Net | 183 | 198 | 213 | 200 | 205 |
| Other Non-Current Assets | 4,027 | 907 | 807 | 943 | 1,075 |
| TOTAL | $4,210 | $1,105 | $1,020 | $1,143 | $1,280 |
| Total Assets | $44,090 | $40,920 | $50,766 | $63,565 | $52,825 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,781 | 1,183 | 1,130 | 1,045 | 434 |
| Accrued Expenses | 7,353 | 8,525 | 8,218 | 9,099 | 7,599 |
| TOTAL | $24,144 | $9,708 | $9,348 | $10,144 | $8,033 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,299 | 0 | 183 | 361 | 535 |
| TOTAL | $3,299 | $N/A | $183 | $361 | $535 |
| Total Liabilities | $27,443 | $9,708 | $9,531 | $10,505 | $8,568 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,852 | 47,852 | 47,638 | 47,310 | 37,310 |
| Common Shares | 48 | 48 | 48 | 48 | 38 |
| Retained earnings | -246,858 | -231,596 | -219,577 | -207,186 | -195,156 |
| TOTAL | $16,647 | $31,212 | $41,235 | $53,060 | $44,257 |
| Total Liabilities And Equity | $44,090 | $40,920 | $50,766 | $63,565 | $52,825 |